We found aggravated atherosclerosis development in aged AAV-PCSK9 mice, with elevated plaque inflammation, increased cellular senescence, and impaired humoral immunity compared to young AAV-PCSK9 mice, contributing to a pro-atherogenic environment. This evidence concerns the gene PCSK9 and atherosclerosis.